Cite
HARVARD Citation
Zhang, B. et al. (2021). A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters. Emerging microbes & infections. 10 (1), pp. 874-884. [Online].